The live audio webcast and the accompanying slide presentations can be accessed through the Calendar of Events section of the Company’s website at ir.kitepharma.com. A replay of the webcast will be available on the Company’s website for two weeks following the event.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT(TM)) designed to restore the immune system’s ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.
For Media: Justin Jackson Burns McClellan 212-213-0006 firstname.lastname@example.org For Investor Day Inquiries: Ami Bavishi Burns McClellan 212-213-0006, ext. 344 email@example.com